Zhengye Biotechnology Holding (ZYBT) Non-Current Debt (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Non-Current Debt data on file, last reported at $1.2 million in Q4 2025.

• Non-Current Debt for Q4 2025 came in at $1.2 million, up 86.73% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.2 million (up 86.73% YoY), and the FY2025 annual result was $1.3 million, up 92.4% from the prior year.
• Non-Current Debt improved to $1.2 million in Q4 2025 per ZYBT's latest filing, from $656000.0 in the prior quarter.
• Over five years, Non-Current Debt peaked at $1.2 million in Q4 2025 and troughed at $54582.7 in Q4 2023.
• A 3-year average of $656650.7 and a median of $662117.7 in 2024 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2024 and 2025: Non-Current Debt surged 1124.26% in 2024, then soared 86.73% in 2025.
• A 3-year view of Non-Current Debt shows it stood at $54582.7 in 2023, then surged by 1124.26% to $668235.5 in 2024, then soared by 86.73% to $1.2 million in 2025.
• Business Quant data shows ZYBT's Non-Current Debt at $1.2 million in Q4 2025, $656000.0 in Q2 2025, and $668235.5 in Q4 2024.